BLEOMYCIN SULFATE
HODGKIN'S LYMPHOMA·+8
APP PHARMACEUTI
Indication
Pleural malignant effusion
Pleural malignant effusion, commonly termed malignant pleural effusion, is an abnormal accumulation of fluid in the pleural cavity directly caused by the presence of neoplastic cells. Read more about Pleural malignant effusion
31 drugs 24 manufacturers
Drugs that treat it
Common Pleural malignant effusion therapies.
MUSTARGEN (mechlorethamine HCl)
HODGKIN'S LYMPHOMA·+10
LUNDBECK INC.
SCLEROSOL (talc)
INTRAPLEURAL SCLEROSING AGENTS·PLEURAL MALIGNANT EFFUSION
BRYAN CORP.
STERILE TALC (talc)
INTRAPLEURAL SCLEROSING AGENTS·PLEURAL MALIGNANT EFFUSION
BRYAN CORP.
BLEOMYCIN (bleomycin sulfate)
HODGKIN'S LYMPHOMA·+8
SICOR PHARM.
BLEOMYCIN SULFATE
HODGKIN'S LYMPHOMA·+8
Teva Parenteral Medicines
BLEOMYCIN SULFATE
HODGKIN'S LYMPHOMA·+8
HOSPIRA
THIOTEPA
CARCINOMA OF BREAST·+6
WEST-WARD,INC.
BLEOMYCIN SULFATE
BLEOMYCIN·HODGKIN'S LYMPHOMA·+8
APP/FRESENIUS K
Filter & compare in the drug finder →Opens the drug finder with Pleural malignant effusion preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPleural malignant effusion, commonly termed malignant pleural effusion, is an abnormal accumulation of fluid in the pleural cavity directly caused by the presence of neoplastic cells.
This condition primarily affects patients with advanced thoracic or extrathoracic malignancies, arising most frequently from secondary metastatic disease—particularly lung and breast cancers—or less commonly from primary pleural tumors such as malignant mesothelioma.
Pathophysiologically, tumor infiltration of the parietal or visceral pleura disrupts normal fluid homeostasis by triggering hyperpermeability of local microvessels, inciting inflammation, and obstructing lymphatic drainage.
Clinically, it presents as an exudative effusion that causes progressive dyspnea, cough, and chest discomfort, and its diagnosis is confirmed by identifying malignant cells within pleural fluid cytology or pleural biopsy tissue.
- nih.gov
Pleural malignant effusion, commonly termed malignant pleural effusion, is an abnormal accumulation of fluid in the pleural cavity directly caused by the presence of neoplastic cells This condition primarily affects patients with advanced thoracic or extrathoracic malignancies, arising most frequently from secondary metastatic disease—particularly lung and breast cancers—or less commonly from primary pleural tumors such as malignant mesothelioma Pathophysiologically, tumor infiltration of the pa...
- nih.gov
Pleural malignant effusion, commonly termed malignant pleural effusion, is an abnormal accumulation of fluid in the pleural cavity directly caused by the presence of neoplastic cells Clinically, it presents as an exudative effusion that causes progressive dyspnea, cough, and chest discomfort, and its diagnosis is confirmed by identifying malignant cells within pleural fluid cytology or pleural biopsy tissue
- nih.gov
This condition primarily affects patients with advanced thoracic or extrathoracic malignancies, arising most frequently from secondary metastatic disease—particularly lung and breast cancers—or less commonly from primary pleural tumors such as malignant mesothelioma
- nih.gov
This condition primarily affects patients with advanced thoracic or extrathoracic malignancies, arising most frequently from secondary metastatic disease—particularly lung and breast cancers—or less commonly from primary pleural tumors such as malignant mesothelioma
- nih.gov
Pathophysiologically, tumor infiltration of the parietal or visceral pleura disrupts normal fluid homeostasis by triggering hyperpermeability of local microvessels, inciting inflammation, and obstructing lymphatic drainage Clinically, it presents as an exudative effusion that causes progressive dyspnea, cough, and chest discomfort, and its diagnosis is confirmed by identifying malignant cells within pleural fluid cytology or pleural biopsy tissue
- nih.gov
Clinically, it presents as an exudative effusion that causes progressive dyspnea, cough, and chest discomfort, and its diagnosis is confirmed by identifying malignant cells within pleural fluid cytology or pleural biopsy tissue
Personalize your experience
Follow Pleural malignant effusion and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.